(NewsDirect)
Futura Medical PLC (AIM:FUM, OTC:FAMDF)CEO James Barder speaks to Thomas Warner from Proactive London afterthe pharmaceutical company announced another milestone in its globalexpansion efforts.
Barder sharesthe news that the Futura has reached an agreement to expand itspresence in Latin America. Initially, Futura Medical had been workingwith key markets in Mexico and Brazil, and their agreement with localpartner M8 Pharmaceuticals confirmed their interest in expanding tothe rest of Latin America.
The dealfollows others in markets around the world. Barder mentions that thecompany has received regulatory approval in Mexico and is preparingfor its launch there, and they anticipate several more launches in thecoming months.
The company remainson track to execute up to 10 launches between now and the end ofApril.
He acknowledges thefrustration among shareholders due to the declining share price inrecent months. He attributed this decline, in part, to macroeconomicfactors and interest rate uncertainty. While the company is activelyexploring ways to address this issue, Barder emphasises that theprimary focus remains on product commercialisation and expansion.
Despite the share price challenges, Barder says that FuturaMedical maintains a robust balance sheet and is fully funded tosupport its ongoing growth initiatives.
ContactDetails
Proactive UK Ltd
+44 20 7989 0813
Copyright (c) 2023 TheNewswire - All rights reserved.